Information Request Form
Please enter your message below. Your mesage will be emailed directly to the contact associated with the press release upon the submission of the form.
Press Release:
BioVie Announces Second Patient Dosed with BIV201 in Phase 2a Clinical Trial; First Patient Completes 28-day Treatment Regimen
Press Release Date:
Nov 08, 2017 @ 07:00 AM ET
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)